July 12, 2019 Neon and Neurotrope await signs of proof of concept Neon Therapeutics is due to unveil the first rigorous test of its neoantigen approach to fighting tumours, while Neurotrope makes a brave bid in Alzheimer's.
April 14, 2017 Upcoming events – Neurotrope aims for Alzheimer’s while brigatinib comes late to the Alk party
